Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orient Molecular Group (OrientMG) is a biotechnology company specializing in molecular diagnostics and precision medicine solutions within the Asian market. Based in Hong Kong, the company provides a comprehensive suite of services including Next-Generation Sequencing (NGS), bioinformatics, and clinical laboratory testing. OrientMG acts as a strategic partner for international life science companies, facilitating the registration and distribution of innovative diagnostic technologies in Greater China. Their clinical focus spans oncology, reproductive health, and infectious diseases, aiming to provide clinicians with actionable genomic insights. The company operates state-of-the-art laboratories and maintains a robust network of clinical and academic collaborations to advance personalized healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OrientMG.